Skip to main content
. 2021 May 10;179(4):526–541. doi: 10.1111/bph.15485

FIGURE 4.

FIGURE 4

Clinically approved GLP‐1 mimetics prescribed for the treatment of diabetes. Structural modifications of GLP‐1 mimetics, compared with native GLP‐1, are highlighted in gold. Information on drug half‐lives, dosage and date of initial approval is also included. *Withdrawn from the market in 2018